Skip to main content

Table 5 Characteristics of conantokins. Their amino acid sequences, respective species, target, clinical potential and references are indicated

From: In the picture: disulfide-poor conopeptides, a class of pharmacologically interesting compounds

Peptide

Amino acid sequence

Species

Target

Clinical potential

Source

Conantokin-G

GEyyLQyNQyLIRyKSNa

C. geographus

NR2B > NR2C, NR2D

pain/epilepsy

[28, 77]

Con-T

GEyyYQKMLyNLRyAEVKKNAa

C. tulipa

NR2B, NR2A

 

[29]

Con-R

GEyyVAKMAAyLARyNIAKGCKVNCYPa

C. radiatus

NR2B, NR2A

 

[35]

Con-L

GEyyVAKMAAyLARyDAVNa

C. lynceus

?

 

[78]

Con-Ca2

GYγγRγIAγTVRγLEEA

C. caracteristicus

?

 

[79]

Con-Gm

GAKyRNNAyAVRyRLEEI

C. gloriamaris

?

 

[79]

Con-Qu

GYγγRγVAγTVRγLDAA

C. quercinus

?

 

[79]

Con-Oc

GEγγRKAMAγLEAKKAQγALKA

C. orchroleucus

?

 

[79]

Con-Pr1

GEDγYAγGIRγYQLIHGKI

C. parius

NR2B, NR2D

 

[80]

Con-Pr2

DEOγYAγAIRγYQLLKYGKI

C. parius

NR2B < NR2D

 

[80]

Con-Pr3

GEOγVAKWAγGLRγKAASNa

C. parius

NR2B, NR2D

 

[80]

Con-E

GEγγHSKYQγCLRγIRVNNVQQγC

C. ermineus

?

 

[77]

Con-P

GEγγHSKYQγCLRγIRVNKVQQγC

C. purpurascens

NR2B, NR2A

 

[77]

Con-Br

GDγγYSKFIγRERγAGRLDLSKFP

C. sulcatus (brettinghami)

NR2B, NR2D, NR2A < NR2C

 

[81]

  1. aN-terminal amidation; Gla: γ-carboxyglutamic acid; NR2: NMDA receptor